Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study

• Main Authors: Mahmoud M. A. Elsayed (Author), Moustafa O. Aboelez (Author), Mohamed S. Mohamed (Author), Reda A. Mahmoud (Author), Ahmed A. El-Shenawy (Author), Essam A. Mahmoud (Author), Ahmed A. Al-Karmalawy (Author), Eman Y. Santali (Author), Sameer Alshehri (Author), Mahmoud Elkot Mostafa Elsadek (Author), Mohamed A. El Hamd (Author), Abd El hakim Ramadan (Author)
• Format: Book
• Published: MDPI AG, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Hyperlipidemia is still the leading cause of heart disease in patients with hypertension. The purpose of this study is to make rosuvastatin calcium (ROS) and atenolol (AT) bilayer tablets to treat coexisting dyslipidemia and hypertension with a single product. ROS was chosen for the immediate-releas...